Marker Therapeutics (MRKR) Revenue (2017 - 2025)
Marker Therapeutics' Revenue came in at $1.1 million for Q4 2025, down 51.0% from $2.25 million a year earlier and down 10.5% from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) Revenue (2017 - 2025) Analysis & Trends
For FY2025, Marker Therapeutics' Revenue was $3.55 million, down 46.2% from FY2024.
- Revenue carries a five-year compound annual growth rate of 48.0% (FY2020 to FY2025).
- Going back by year, Revenue was $6.59 million in FY2024 (+99.1%), $3.31 million in FY2023 (-5.8%), $3.51 million in FY2022 (+183.0%) and $1.24 million in FY2021 (+148.3%).
- The five-year range for quarterly Revenue is -$503,005 (Q2 2023) to $2.5 million (Q1 2023).
- Year-over-year, Revenue has declined for four consecutive quarters, with growth averaging 75.0% over the last seven quarters.
- The fastest year-over-year change in Revenue over five years came in Q3 2024 (growth of 647.7%), and the weakest in Q3 2023 (a decline of 74.2%).
- Business Quant data shows MRKR's Revenue at $1.23 million (Q3 2025), $861,184 (Q2 2025) and $349,104 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Marker Therapeutics | 17.87 Mn | -42.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 861,184.00 |
| Mar 31, 2025 | 349,104.00 |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.24 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 257,606.00 |
| Dec 31, 2022 | 759,143.00 |
| Sep 30, 2022 | 999,571.00 |
| Jun 30, 2022 | 790,508.00 |
| Mar 31, 2022 | 964,322.00 |
| Dec 31, 2020 | 33,215.00 |
| Jun 30, 2020 | 466,785.00 |
| Dec 31, 2019 | 213,194.00 |
| Jun 30, 2018 | 205,994.00 |
| Sep 30, 2017 | 183,064.00 |
API Access
Marker Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();